NGS has been mostly a topic of research and development in the previous decade . At present they find applications in the field of oncology , prenatal testing , HLA testing , idiopathic diseases , and medical research . Research and development in the field of HLA and prenatal testing have provided new avenues to doctors in gaining insights during organ matching and organ rejection .
The development in the treatment of genetic anomalies and diseases with the help of prenatal genome sequencing has been driving the NGS market . This technology has also helped the pharmaceutical companies in developing essential drugs for the treatment of cancer and infectious diseases . Growing concerns and increasing incidences of cancer is expected to be the major driving factor for the development of NGS .
NGS in the field of organ transplant provides great opportunities over the forecast period . It is important that the characteristics of both the donors and the acceptors match for a successful transplant . NGS helps in studying the immune response to the transplanted organ . Medical tourism development in countries including the U . S , Israel , Singapore and Australia provide bright prospects for overall growth of the market .
Browse Full Research Report @ https :// www . millioninsights . com / industry-reports / next-generation-sequencing-ngs-market
Next generation sequencing market is segmented as target , genome , exon and resequencing . The largest share is held by target sequencing followed by genome sequencing . Development of whole genome sequencing capabilities is expected to show a significant growth over the forecast period . Whole genome technology is relatively new and is gaining popularity with the development of high throughput . This high throughput has helped in reducing complications associated with whole genome sequencing .
NGS includes sample enrichment , DNA tagging , library preparation , sample quality assurance , DNA quantification , data storage , genetic data assembly , analysis and interpretation . With the increase in volume of whole genome sequencing , next generation data analysis is expected to observe a significant growth over the forecast period .
Government regulatory bodies play a vital role in overall development and usage of these technologies . Medical device manufacturers in the U . S . are under the strict vigilance of Food and Drug Administration ( FDA ). In 2013 , FDA approved four next generation gene sequencing devices which is expected to help physicians in taking a broader look at the patient ’ s genetic makeup . Two of the approved devices is expected to help in detecting DNA changes in the treatment of cystic fibrosis .
North America is expected to observe highest demand in the global industry on account of the well-developed healthcare sector and implementation of advanced research infrastructure . Similarly , Western Europe is